The REVEAL Registry™ is a multicenter, observational, U.S.-based registry study of pulmonary arterial hypertension (PAH). REVEAL is the only national registry study of its kind, and it is designed to bridge the gap between science and practice by characterizing the current management and clinical features of patients with PAH.